{
    "clinical_study": {
        "@rank": "1455", 
        "arm_group": [
            {
                "arm_group_label": "lactobacillus reuteri", 
                "arm_group_type": "Experimental", 
                "description": "Intervention: supplementation with the probiotic Lactobacillus reuteri (DSM 17938),Reuflor, was administered in the dose of 108 colony-forming units (CFU) in tablets of a commercially available preparation (Reuflor, Italchimici, Pomezia; BioGaia AB, Stockholm, Sweden), 30 minutes after feeding, twice per day for 4 weeks."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "a supplementation with placebo was administered in tablets of a commercially available preparation 30 minutes after feeding, twice per day for 4 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "A double-blind, placebo Randomized Controlled Trial, To evaluate the effects of L. reuteri\n      in adult patients with functional constipation."
        }, 
        "brief_title": "Lactobacillus Reuteri in Adult With Functional Chronic Constipation", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Functional Constipation", 
        "condition_browse": {
            "mesh_term": "Constipation"
        }, 
        "detailed_description": {
            "textblock": "Patients affected by functional constipation according to Rome III criteria. The increase of\n      Bowel Movements/week frequency  was the primary outcome, while the improvement of stool\n      consistency was the secondary outcome."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  functional constipation rome III\n\n        Exclusion Criteria:\n\n          -  hypothyroidism or other metabolic or renal abnormalities, or\n\n          -  antibiotic's treatment,\n\n          -  probiotic or prebiotic supplementation in the last month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01870700", 
            "org_study_id": "no one"
        }, 
        "intervention": [
            {
                "arm_group_label": "lactobacillus reuteri", 
                "description": "Lactobacillus reuteri (DSM 17938) was administered in the dose of 108 colony-forming units (CFU) in tablets of a commercially available preparation (Reuflor, Italchimici, Pomezia; BioGaia AB, Stockholm, Sweden), 30 minutes after feeding, twice per day for 4 weeks", 
                "intervention_name": "lactobacillus reuteri", 
                "intervention_type": "Drug", 
                "other_name": "Reuflor"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "a supplementation with placebo was administered in tablets of a commercially available preparation 30 minutes after feeding, twice per day for 4 weeks", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug", 
                "other_name": "placebo"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "state": "Italy/rome", 
                    "zip": "00168"
                }, 
                "name": "Catholic University Sacred Heart"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Lactobacillus Reuteri Supplementation to Adult With Functional Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial", 
        "overall_official": {
            "affiliation": "catholic university", 
            "last_name": "veronica ojetti", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The increase of BMs/week frequency", 
            "safety_issue": "No", 
            "time_frame": "January to June 2012 (up to 6 months)"
        }, 
        "reference": {
            "PMID": "20542295", 
            "citation": "Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr. 2010 Oct;157(4):598-602. doi: 10.1016/j.jpeds.2010.04.066. Epub 2010 Jun 12."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01870700"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Catholic University, Italy", 
            "investigator_full_name": "veronica ojetti", 
            "investigator_title": "adjunt professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "the improvement of stool consistency", 
            "safety_issue": "No", 
            "time_frame": "january to june 2012 (up to 6 months)"
        }, 
        "source": "Catholic University, Italy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Catholic University, Italy", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}